About Verthermia
Verthermia is a Medical Device company, headquartered in Henderson, with 11 - 50 employees and annual revenue of $1M - $5M.
The company was formed in 2012 to further develop whole body hyperthermia (WBH) as a viable cancer therapy. Verthermia is using Heat to Treat cancer and is currently in a Phase I ovarian clinical trial.
Seamless Pro Tip
Use this information to figure out if this company is an ideal customer for you.
Verthermia Company Highlights
Phone Number
(866) 432-xxxx
Corporate Office Address
1887 Whitney Mesa Drive
Henderson, 89014
Website
Verthermia Org
Verthermia has 2 VP employees.
Verthermia Decision Makers
- CFODavid E Wilder
Verthermia's Tech Stack
Frequently Asked Questions About
Verthermia
Log in or sign up to get full contact details and additional support.
Who is the CFO of Verthermia?
The CFO of Verthermia is David E Wilder. See full contact details ›
How many senior employees does Verthermia have?
Verthermia has 2 senior employees that are typically used for decision making.
Who are the key decision makers at Verthermia?
Key decision makers at Verthermia include David E Wilder (CFO). See full contact details ›
What technologies does Verthermia use?
Verthermia uses technologies including Curalate, Fastly, and Flywheel.
How do I contact Verthermia?
To contact Verthermia, visit verthermia.com.
What companies are similar to Verthermia?
Companies similar to Verthermia include Biocartis, Fujifilm Sonosite Inc., and Dentalez.
Where is Verthermia headquartered?
Verthermia is headquartered at 1887 Whitney Mesa Drive, Henderson.
What is the main phone number for Verthermia?
The main phone number for Verthermia is (866) 432-xxxx.
What is the official website for Verthermia?
The official website for Verthermia is verthermia.com.
What is the annual revenue of Verthermia?
The annual revenue of Verthermia is $1M - $5M.
How many employees does Verthermia have?
Verthermia has 11 - 50 employees.
What industry is Verthermia in?
Verthermia is in the Medical Device industry.
Last updated: May 28, 2025